MR van den Bergh, J Spijkerman… - The Pediatric …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ... Related articles - All 4 versions
[PDF] from hindawi.comT Kamoltham, W Thinyounyong, P Khawplod… - 2011 - downloads.hindawi.com 1 Office of Permanent Secretary, Ministry of Health, Nonthaburi 11120, Thailand 2 Provincial Health Office of Phetchabun, Ministry of Health, Phetchabun 67160, Thailand 3 Queen Saovabha Memorial Institute, Thai Red Cross Society and Department of Medicine, Chulalongkorn ... Related articles - View as HTML
Q Wu, GH Zhuang, XL Wang, LR Wang, N Li… - Vaccine, 2011 - Elsevier The duration of protection of hepatitis B vaccine remains incompletely understood. To assess the long-term protection provided by a primary vaccine series, the current study again recruited all subjects of a previous randomized placebo-controlled trial cohort 23 years after ... Related articles - All 3 versions
RC Li, FX Li, YP Li, QM Hou, CG Li, YN Li… - Vaccine, 2011 - Elsevier The aim was to demonstrate the immunogenicity and safety of a DTaP-IPV//PRP-T combined vaccine (Pentaxim ® ) compared to individual vaccines in infants in the People's Republic of China. Infants (N = 792) were randomly assigned to receive DTaP-IPV//PRP-T at 2, 3 and ... Related articles - All 3 versions
J Yao, J Ren, L Shen, Y Chen… - Human …, 2011 - landesbioscience.com The twin aims of this study were to investigate the changes in anti-HBs IgG levels after booster vaccinations and to compare the effects of different vaccine doses in children aged 11-15 years who were both negative for HBsAg and had an Anti-HBs <10.0 mIU/mL after primary ... Cached